| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/12/2012 | US20120009151 Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof |
| 01/12/2012 | US20120007063 Use of dibenzofurans and dibenzothiophenes substituted by nitrogen-bonded five-membered heterocyclic rings in organic electronics |
| 01/12/2012 | CA2805452A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 01/12/2012 | CA2803717A1 (3-methylpyrrolidin-3-yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists |
| 01/11/2012 | EP2404919A1 Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters. |
| 01/11/2012 | EP2404905A1 New compounds |
| 01/11/2012 | EP2404902A1 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism |
| 01/11/2012 | EP2404901A1 1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
| 01/11/2012 | EP2404890A1 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 01/11/2012 | EP2403852A1 3h-imidazo [4, 5 -c]pyridine- 6 -carboxamides as anti- inflammatory agents |
| 01/11/2012 | EP2403848A1 Pharmaceutical hypocholesterolemic compositions |
| 01/11/2012 | EP2403844A1 Heterocyclic antiviral compounds |
| 01/11/2012 | EP2173735B1 Imidazole derivatives as ccr2 receptor antagonists |
| 01/11/2012 | EP1763518B1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 01/11/2012 | EP1486549B1 Organic electroluminescent element |
| 01/11/2012 | EP1458687B1 Pyrimidine compounds as interleukin-12 (il-12) inhibitors |
| 01/11/2012 | CN1761660B Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles |
| 01/11/2012 | CN1642542B Angiogenesis inhibitors |
| 01/11/2012 | CN102317284A Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
| 01/11/2012 | CN102317282A Hetero ring derivative |
| 01/11/2012 | CN102317281A Pyrimidinones as casein kinase ii (CK2) modulators |
| 01/11/2012 | CN102317279A Tetrazole substituted anthranilic acid amides as pesticides |
| 01/11/2012 | CN102317277A C-met protein kinase inhibitors |
| 01/11/2012 | CN102317275A Novel herbicides |
| 01/11/2012 | CN102317269A Novel amino azaheterocyclic carboxamides |
| 01/11/2012 | CN102316900A Aniline derivative having anti-rna viral activity |
| 01/11/2012 | CN102311427A Rosinyl epoxy resin with bismaleimide structure and preparation method thereof |
| 01/11/2012 | CN102311416A Hydroxy substituted flavonoid compound, preparation method and application thereof |
| 01/11/2012 | CN102311399A Triazole alcohol antifungal compounds with nitrogen-containing side chains, preparation method thereof and application thereof |
| 01/11/2012 | CN102311398A Triazole compounds, preparation method thereof, and application thereof in preparing histone deacetylase I inhibitor |
| 01/11/2012 | CN102311387A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 01/11/2012 | CN101370786B Substituted imidazoles and their use as pesticides |
| 01/11/2012 | CN101346353B Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 01/10/2012 | US8093389 e.g. 1-[(1-Ethyl-4-methoxy-1H-benzimidazol-6-yl)carbonyl]-6-(1H-tetrazol-5-yl)spiro[chroman-2,4'-piperidine]-4-one; acetyl CoA carboxylase inhibitors; antidiabetic, hypoglycemic agent; metabolic syndrome, fatty liver, hyperlipemia, obesity, diabetes, bulimia, malignant neoplasm or infectious diseases |
| 01/10/2012 | US8093380 Compounds with the bicyclo[4.2.1]nonane system for the treatment of Flaviviridae infections |
| 01/10/2012 | US8093250 2-aminocarbonyl-pyridine derivatives |
| 01/10/2012 | CA2528653C Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
| 01/10/2012 | CA2526079C Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
| 01/10/2012 | CA2486183C Protein kinase inhibitors |
| 01/05/2012 | WO2012003498A1 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds |
| 01/05/2012 | WO2012003405A1 Sgc stimulators |
| 01/05/2012 | WO2012003283A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | WO2012003274A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | WO2012003164A1 Benzofuran derivatives for the treatment of hepatits c |
| 01/05/2012 | WO2012002741A2 Process for the preparation of hmg-coa reductase inhibitors and intermediates thereof |
| 01/05/2012 | WO2012002577A1 Novel nicotinamide derivatives or salts thereof |
| 01/05/2012 | WO2012002527A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
| 01/05/2012 | WO2012002096A1 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides |
| 01/05/2012 | WO2012001107A1 Piperidine derivatives and their use for the treatment of metabolic disorders |
| 01/05/2012 | WO2012001020A1 Novel tetrahydroquinoline derivatives |
| 01/05/2012 | US20120004428 Tri-Substituted 2-Benzhydryl-5-Benzylamino-Tetrahydro-Pyran-4-OL and 6-Benzhydryl-4-Benzylamino-Tetrahydro-Pyran-3-OL Analogues, and Novel 3,6-Disubstituted Pyran Derivatives |
| 01/05/2012 | US20120004416 Novel method for producing enaminocarbonyl compounds |
| 01/05/2012 | US20120004408 Use of Rosuvastatin Lactols as Medicaments |
| 01/05/2012 | US20120004255 Dual phase drug release system |
| 01/05/2012 | US20120004252 New ccr2 receptor antagonists and uses thereof |
| 01/05/2012 | US20120004244 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004230 Imidazole derivatives |
| 01/05/2012 | US20120004224 Triheterocyclic Compounds and Compositions Thereof |
| 01/05/2012 | US20120004218 Novel tetrahydro-quinoline derivatives |
| 01/05/2012 | US20120004196 Anti-Viral Compounds |
| 01/05/2012 | US20120004101 Novel Heterocyclic Alkanol Derivatives |
| 01/05/2012 | US20120003270 6-substituted isoflavonoid compounds and uses thereof |
| 01/05/2012 | US20120003229 Modulators of cytokine mediated signalling pathways and integrin alphavbeta3 receptor antagonists for combination therapy |
| 01/05/2012 | CA2804319A1 Benzofuran derivatives for the treatment of hepatits c |
| 01/05/2012 | CA2804225A1 Heterocyclic compound and p27kip1 degradation inhibitor |
| 01/05/2012 | CA2803996A1 Piperidine derivatives and their use for the treatment of metabolic disorders |
| 01/05/2012 | CA2803842A1 Novel nicotinamide derivative or salt thereof |
| 01/05/2012 | CA2803752A1 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides |
| 01/05/2012 | CA2803478A1 Novel tetrahydroquinoline derivatives |
| 01/05/2012 | CA2803358A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | CA2803292A1 Sgc stimulators |
| 01/05/2012 | CA2803009A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | CA2802492A1 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds |
| 01/04/2012 | EP2402334A1 Inhibitors of E1 Activating Enzymes |
| 01/04/2012 | EP2402324A1 Benzodioxolylcyclopropylpiperazinylpyridazines |
| 01/04/2012 | EP2402320A1 Anorectic agents |
| 01/04/2012 | EP2402319A1 DGAT Inhibitors |
| 01/04/2012 | EP2402318A1 DGAT inhibitors |
| 01/04/2012 | EP2402314A1 (Aza)indole derivative and use thereof for medical purposes |
| 01/04/2012 | EP2402310A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402309A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402300A1 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 01/04/2012 | EP2401267A1 Jak kinase modulating quinazoline derivatives and methods of use thereof |
| 01/04/2012 | EP2401256A1 Compounds as bradykinin b1 antagonists |
| 01/04/2012 | EP2400846A1 Hepatitis c virus inhibitors |
| 01/04/2012 | EP2049502B1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/04/2012 | EP1735286B1 Tetrahydro-indazole cannabinoid modulators |
| 01/04/2012 | CN1972921B 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 01/04/2012 | CN102307872A BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 01/04/2012 | CN102307871A Isoindolinone and related analogs as sirtuin modulators |
| 01/04/2012 | CN102307870A Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of disease |
| 01/04/2012 | CN102307867A Dihydroquinolinone derivatives |
| 01/04/2012 | CN102307861A Phenylimidazole compounds |
| 01/04/2012 | CN102304112A Vesicle with two-photon excitation controlled-release function, and preparation method and application thereof |
| 01/04/2012 | CN102304110A Hydroxamates as therapeutic agents |
| 01/04/2012 | CN102304091A Emodin and fluorouracil combined compound having antitumor activity and preparation method thereof |
| 01/04/2012 | CN102304075A Inhibitors of viral replication |
| 01/04/2012 | CN101856623B Phenylpropyl-12-crown-4imidazole carbene catalyst and preparation method and application thereof |
| 01/04/2012 | CN101155783B Pyrazoles |
| 01/03/2012 | US8088924 Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |